Cargando…
Phytochemicals against SARS-CoV as potential drug leads
The newly emerged SARS-CoV-2 strains from the coronavirus (CoV) family is causing one of the most disruptive pandemics of the past century. Developing antiviral drugs is a challenge for the scientific community and pharmaceutical industry. Given the health emergency, repurposing of existing antivira...
Autores principales: | Swain, Shasank Sekhar, Panda, Sujogya Kumar, Luyten, Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chang Gung University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726715/ https://www.ncbi.nlm.nih.gov/pubmed/33736953 http://dx.doi.org/10.1016/j.bj.2020.12.002 |
Ejemplares similares
-
Metabolic Diversity and Therapeutic Potential of Holarrhena pubescens: An Important Ethnomedicinal Plant
por: Zahara, Kulsoom, et al.
Publicado: (2020) -
Anticancer Activities of Mushrooms: A Neglected Source for Drug Discovery
por: Panda, Sujogya Kumar, et al.
Publicado: (2022) -
Potential of Marine Terpenoids against SARS-CoV-2: An In Silico Drug Development Approach
por: Sahoo, Alaka, et al.
Publicado: (2021) -
Ethnomedicinal, Phytochemical and Pharmacological Investigations of Tetradenia riparia (Hochst.) Codd (Lamiaceae)
por: Panda, Sujogya Kumar, et al.
Publicado: (2022) -
Potential drug leads for SARS-CoV2 from phytochemicals of Aerva lanata: a Machine Learning approach
por: Sherin, D. R., et al.
Publicado: (2021)